Basic InformationLatest News
How to Care for Your Skin During Radiation TherapyWhat You Need to Know About Your Colon Cancer RiskMore Prostate Cancers Are Being Diagnosed at a Later StageMany Male Breast Cancers Diagnosed Late, and Delays Can Be LethalCancer Takes Heavy Toll on Women's Work and Finances: StudyDNA Analysis Might Reveal Melanoma RiskDrug Combo Approved for First-Line Treatment of MesotheliomaRadiation Plus Surgery May Be Best Against an Early Form of Breast CancerImmunotherapy Drug Boosts Survival for Lung Cancer PatientsBreast Cancer Treatment Comes Later, Lasts Longer for Black WomenSmoking Reduces Survival Odds After Bladder Cancer SurgeryCertain Cancer Treatments May Heighten Danger From COVID-19Is an Early Form of Breast Cancer More Dangerous Than Thought?Immunotherapy Drug Boosts Survival With Bladder CancerMany High-Risk Patients Don't Know They Need Follow-Up ColonoscopyAlmost 90,000 Young American Adults Will Get Cancer This Year: ReportCoffee May Slow Spread of Colon CancerAHA News: Immune-Boosting Cancer Treatment May Pose Cardiovascular RiskWhy Do Black Men Still Fare Worse With Prostate Cancer?No Link Found Between Blood Pressure Meds and Cancer: StudyCatch Prostate Cancer Early – It Could Save Your Life'Spare Tire' Might Up a Man's Prostate Cancer RiskCancer Radiation Can Safely Proceed During COVID-19 Pandemic: StudyMany Thyroid Cancer Ultrasound Scans UnnecessaryCan Women With Early Breast Cancer Skip Post-Op Radiation?Delaying Prostate Cancer Radiation Won't Lower Survival OddsBetter Treatments Bring Better Survival After Lung CancerCould Daily Low-Dose Aspirin Hasten Cancer in Seniors?Many Older Americans Getting Cancer Screens They Don't Need: StudyCancer Diagnoses Plunge as Americans Avoid Screening During PandemicAggressive Cancer Diagnosed for First Time in a DinosaurFew U.S. Women Know About Cancer That Develops Near Breast Implants: StudyTecartus Approved for Treatment of Mantle Cell LymphomaBlood Test Might Spot Cancer Years EarlierFor Cancer Patients, Getting COVID-19 Raises Death Risk 16-FoldKeep Flossing: Study Ties Gum Disease to Higher Cancer RiskTough Decisions as COVID-19 Causes Cancer Surgery DelaysHow to Protect Yourself From the Sun's Harmful UV RaysBlacks Underrepresented in Cancer Drug Trials: StudyNew Guidelines Could Double Number Eligible for Lung Cancer ScreeningBreast Cancer Caught Earlier in U.S. States With Expanded Medicaid: StudyObamacare Helps Poorer Americans Spot Cancer Earlier: StudyCommon Blood Pressure Meds May Lower Colon Cancer RiskHow Insurance Plans Keep Black Patients From Cancer CareStatins Tied to Significantly Lower Death Rate From Ovarian CancerNew Blood Test May Improve Liver Cancer ScreeningCancer Patients Less Likely to Be Prescribed Heart Meds: StudyBreast Cancer Takes Big Financial Toll on Some Young PatientsLoving Partners May Be Key to Breast Cancer Survivors' Health'Lab-on-a-Chip' Blood Test Could Spot Breast Cancer Early
VideosLinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

More Prostate Cancers Are Being Diagnosed at a Later Stage

HealthDay News
by By Steven Reinberg
HealthDay Reporter
Updated: Oct 16th 2020

new article illustration

FRIDAY, Oct. 16, 2020 (HealthDay News) -- While men can take solace in a new government report that shows prostate cancer cases have been declining overall in the past two decades, the same analysis finds that the opposite is true for advanced prostate cancer cases.

In fact, the number of cases of cancer that had already spread from the prostate to other parts of the body doubled between 2003 and 2017, going from 4% to 8%, according to researchers from the U.S. Centers for Disease Control and Prevention.

"Understanding who gets prostate cancer and what the survival numbers are like could be important for men making prostate cancer screening decisions, providers discussing these decisions with their patients, and for informing recommendations for prostate cancer screening," said lead researcher Dr. David Siegel, from CDC's Division of Cancer Prevention and Control.

Why the spike in advanced prostate cancers? Dr. Anthony D'Amico, a professor of radiation oncology at Harvard Medical School in Boston, said the increase was an inevitable consequence of a 2012 recommendation from the U.S. Preventive Services Task Force against the routine use of prostate cancer screening with the prostate-specific antigen (PSA) test.

"We realized in 2012, when the U.S. Preventive Services Task Force said to stop PSA screening, we would expect that somewhere around 2018 to 2019 that cancer death rates would start to go up, and that about two to three years prior to that, around 2015 to 2016, we would expect to see distant metastases [cancer that has spread] go up because they preceded death by a couple of years," he explained.

That's exactly what this report found, D'Amico noted.

"That trend will continue because the reversal of the recommendation against PSA screening didn't happen until [2018], so it's going to be a couple of years from now before we start to see a plateauing and eventually a decrease in distant disease," he said. "We should have PSA brought back."

While D'Amico said he believes that men should have their PSA level tested, whether an elevated PSA leads to further diagnosis or treatment should be based on a conversation between a man and his urologist.

"We're diagnosing less low-risk cases now, but there's no problem from my perspective in bringing the PSA back, so that the patients with low-risk cancer can have the discussion whether they want treatment or not, knowing what the side effects are, and the patients who need to be cured can be cured," D'Amico said.

Men are getting more metastatic disease and dying, he said. "But because of the reversal of PSA screening, it should come back to where it was, and the only difference is now we're smarter about who to treat and who not to treat," D'Amico said.

The CDC study also delved into racial differences for prostate cancer survival. The researchers found that five-year survival was highest among Asian/Pacific Islanders (42%), followed by Hispanics (37%), American Indian/Alaska Natives (32%), Black men (32%), and white men (29%).

Understanding prostate cancer rates and survival can help guide treatment and survivor care planning, Siegel said.

This study did not look at PSA testing trends, but past studies have noted decreasing use of PSA testing, Siegel acknowledged. "There are a lot of factors, including decreases in PSA testing, that might contribute to the incidence trends we reported in this study."

The findings were published Oct. 16 in the CDC's Morbidity and Mortality Weekly Report.

More information

For more on PSA tests, see the U.S. Centers for Disease Control and Prevention.


Amazon Smile


Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.


powered by centersite dot net